Showing results (181-190 of 230) with videos related to
Sort By:
Pageof 23
Diabetes Care|January 1, 2013
Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperationGiuseppe De Luca, Maurits T Dirksen, Christian Spaulding, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 2, 2014
Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperationGiuseppe De Luca, Maurits T Dirksen, Christian Spaulding, et al.International Journal of Cardiology|May 24, 2014
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperationGiuseppe De Luca, Maurits T Dirksen, Christian Spaulding, et al.Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.The American Journal of Cardiology|March 16, 2013
Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary interventionGiuseppe De Luca, Maurits T Dirksen, Christian Spaulding, et al.The American Journal of Cardiology|August 26, 2011
Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy)Michael Maeng, Lisette O Jensen, Hans-Henrik Tilsted, et al.The American Journal of Cardiology|May 14, 2013
Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation)Giuseppe De Luca, Maurits T Dirksen, Christian Spaulding, et al.Circulation. Cardiovascular Interventions|October 11, 2012
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality studyJohn A Ormiston, Patrick W Serruys, Yoshinobu Onuma, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2011
In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registryAlfredo R Galassi, Salvatore D Tomasello, Nicolaus Reifart, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2013
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 monthsPatrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, et al.Pageof 23